Vertex to Participate in Upcoming June Investor Conferences
23 5월 2024 - 5:05AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced management participation in two upcoming investor
conferences.
- Dr. Reshma Kewalramani, Chief Executive Officer and President,
will present at the William Blair 44th Annual Growth Stock
Conference on Tuesday, June 4, 2024 at 4:00 p.m. CT.
- Charles Wagner, Executive Vice President and Chief Financial
Officer, and David Altshuler, M.D., Ph.D., Executive Vice
President, Global Research, and Chief Scientific Officer, will
participate in a fireside chat at the Goldman Sachs 45th Annual
Global Healthcare Conference on Tuesday, June 11, 2024 at 11:20
a.m. ET.
A live webcast of management's remarks will be available through
the Vertex website, www.vrtx.com in the "Investors" section under
the "News and Events" page. A replay of the conference webcast will
be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has approved medicines that
treat the underlying causes of multiple chronic, life-shortening
genetic diseases — cystic fibrosis, sickle cell disease and
transfusion-dependent beta thalassemia — and continues to advance
clinical and research programs in these diseases. Vertex also has a
robust clinical pipeline of investigational therapies across a
range of modalities in other serious diseases where it has deep
insight into causal human biology, including acute and neuropathic
pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal
dominant polycystic kidney disease, type 1 diabetes, myotonic
dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex was founded in 1989 and has its global headquarters in
Boston, with international headquarters in London. Additionally,
the company has research and development sites and commercial
offices in North America, Europe, Australia, Latin America and the
Middle East. Vertex is consistently recognized as one of the
industry's top places to work, including 14 consecutive years on
Science magazine's Top Employers list and one of Fortune’s 100 Best
Companies to Work For. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
LinkedIn, Facebook, Instagram, YouTube and Twitter/X.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240522554872/en/
Vertex Pharmaceuticals Incorporated Investors:
InvestorInfo@vrtx.com
Vertex Pharmaceuticals (NASDAQ:VRTX)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024